...the transcription factor ATOH1. Novartis gained worldwide rights to the gene therapy in 2010 from GenVec Inc....
...Koch, Executive Editor; Winnie Pong, Associate Editor, Data & Analytics Cord Blood Registry Otonomy Inc. Pipeline Therapeutics Inc. Novartis AG GenVec Inc. Frequency...

...gene, in Phase I/II testing. Novartis gained exclusive, worldwide rights to CGF166 in 2010 from GenVec Inc....

...CPK850 to treat retinitis pigmentosa. Novartis gained exclusive, worldwide rights to CGF166 in 2010 from GenVec Inc....

...CPK850 to treat retinitis pigmentosa. Novartis gained exclusive, worldwide rights to CGF166 in 2010 from GenVec Inc....

...advanced therapeutic in this area is CGF166 , a gene therapy from Novartis AG and GenVec Inc....
...program in the clinic is CGF166, a gene therapy from Novartis AG (NYSE:NVS; SIX:NOVN) and GenVec Inc....
...BN201 and BN119 for inner ear disorders and anticipates making a decision by 3Q17; (B) GenVec Inc....

...CSP sequence of P. falciparum combined with the AS01 adjuvant, in registration to prevent malaria. GenVec Inc....

...the clinic for hearing loss. One gene therapy, CGF166 from Novartis AG (NYSE:NVS; SIX:NOVN) and GenVec Inc....

...stock deal. GenVec shareholders will receive 0.297 Intrexon shares per GenVec share, or $6.56 per GenVec...
...2016. The price is a 44% premium to GenVec's close of $4.54 on Jan. 23. GenVec...
...Novartis AG (NYSE:NVS; SIX:NOVN, Basel, Switzerland). In 2010, GenVec granted Novartis exclusive, worldwide rights to GenVec's...

...university for IP and technology related to gene editing and pulmonary endothelial cell targeting technology. GenVec...
...in St. Louis , St. Louis, Mo. GenVec Inc. (NASDAQ:GNVC), Gaithersburg, Md. Business: Hematology, Gene/Cell therapy Shannon Lehnbeuter GenVec Inc. Washington...

...normal hearing. Several companies have been exploring regenerative medicine and gene therapy to restore hearing. GenVec Inc....
...details about its financing or investors. Companies and Institutions Mentioned Frequency Therapeutics Inc., Cambridge, Mass. GenVec Inc....